Log In
Print
BCIQ
Print
Print this Print this
 

Pentasa, mesalamine

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionControlled-release mesalamine capsules
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis (UC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today